Patient enrolment completed in first study of olesoxime

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Patient enrolment completed in first study of olesoxime

Postby MSUK » Tue Aug 06, 2013 6:52 am

Patient enrolment completed in first study of olesoxime in relapsing remitting MS

Trophos SA announced today that they have completed enrollment in the Translate MS-Repair Phase Ib multiple sclerosis (MS) trial.

The trial is a randomized, placebo controlled, Phase Ib study in multiple sclerosis (MS) patients treated with Trophos' olesoxime as an add-on therapy to Interferon beta. In three months, 44 patients have been recruited in three investigational sites in France. The first subject was enrolled on April 2 and the last subject on July 11, 2013..... Read More - http://www.ms-uk.org/index.cfm/emergingtherapies
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2178
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service